Bozen, Sud-Tirol, Italy – April 2nd, 2012.
Health Robotics reported 31 new first quarter contracts in 1Q2012, traditionally the weakest on the calendar, with a three-fold increase in sales bookings year-over- year. Health Robotics continued to benefit from its prior decisions to terminate specific contracts with some under-performing distributors, and from switching channel strategies to directly manage customer operations in certain key countries.
Gaspar DeViedma, Health Robotics’ Executive Vice President and Board Member, stated: “We are very pleased with such a strong sales-kickoff for a very important calendar year at Health Robotics, as widely demonstrated with 4 contracts for the implementation of our newest robot i.v.STATION ONCO. We are also encouraged by the market trends we see in the United States of America (4 new “Live” i.v.STATIONs this trimester alone), and within our home country of Italy, among other places. After a 3-year absence in connection with a prior agreement with Loccioni, we have now returned home with a “bang” at the prestigious National Cancer Center, utilizing the same business model already proven in the USA.”
During 1Q2012, Health Robotics signed 31 new installations under contract, including 6 I.V. Robots, 11 i.v.SOFT agreements, and 14 OMM modules at Premier Health Alliance (USA), Imperial College Healthcare NHS Trust (England), National Cancer Center of Milan (Italy), Gregorio Maranon University Hospital (Spain), Healthdyne (South Korea), and AHCSC (Kingdom of Saudi Arabia).
Mr. DeViedma concluded: “With Health Robotics rapidly approaching 150 IV Robot installations under contract [approximately 10 times more IV Robots than all of its worldwide competitors1 combined], the markets have now recognized that Health Robotics’ 2nd Generation modular architecture of networked medical devices are fully automated, offer 3 to 4 times faster speed/throughput, less than half the price, size, and weight, and deliver payback periods/R.O.I. of less than 1 year.”
About Health Robotics: Founded in 2006, Health Robotics is the undisputed global leading supplier of life- critical intravenous medication robots, winning 100% of all worldwide I.V. Robot’s publicly announced purchases in 2010 and 2011, and providing over 250 hospital installations in 5 continents with robotics-based technology and clinical software automation solutions.
Health Robotics’ world-leading solutions CytoCare® and i.v.STATION® ONCO [hazardous IVs], i.v.STATION® [non-hazardous IVs], i.v.SOFT® [workflow engine for sterile compounding], OMM® [Oncology Medication Management], MEDarchiver® [life-critical clinical information system], and TPNstationTM [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals’ growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics’ products help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances’ diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff.
1 Competitors: Loccioni/AEA, IHS/RIVA, MDS (now Fresenius Kabi),FHT/Baxa (now Baxter)
Download in PDF Format :